Catalyst Biosciences to Present at the Annual BIO CEO &

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
14
Catalyst Biosciences to Present at the Annual BIO CEO & Investor Conference

SOUTH SAN FRANCISCO, Calif., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc., (Nasdaq: CBIO) a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced that Nassim Usman, Ph.D., president and chief executive officer, will present a corporate overview at the Annual BIO CEO & Investor Conference, being held in New York City on February 11-12, 2019.

Presentation Details Date:               Tuesday, February 12, 2019 Time:               1:15 p.m. Eastern Time Location:         New York Marriott Marquis

To schedule a meeting with the Catalyst Biosciences management team at this conference, please contact LifeSci Advisors .

About Catalyst Catalyst is a clinical-stage biopharmaceutical company developing novel medicines to address hematology indications. Catalyst is focused on the field of hemostasis, including the subcutaneous prophylaxis of hemophilia and facilitating surgery in individuals with hemophilia. For more information, please visit www.catalystbiosciences.com .

Forward-Looking Statements This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statement of historical facts (including, but not limited to, statements that contain words such as “will,” “believes,” “plans,” “anticipates,” “expects,” “estimates”) are forward-looking statements. Actual results or events could differ materially from the plans, intentions, expectations and projections disclosed in the forward-looking statements. Various important factors could cause actual results or events to differ materially from the forward-looking statements that the Company makes, including, but not limited to, the risk that trials and studies may be delayed and may not have satisfactory outcomes, that human trials will not replicate the results from animal studies, that potential adverse effects may arise from the testing or use of the Company’s products, including the generation of antibodies, the risk that costs required to develop or manufacture the Company’s products will be higher than anticipated, competition and other factors that affect our ability to establish collaborations on commercially reasonable terms and other risks described in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2017 and the Company’s Quarterly Reports on Form 10-Q for the quarters ended March 31, 2017, June 30, 2017, and September 30, 2017 along with other filings with the Securities and Exchange Commission. The Company does not assume any obligation to update any forward-looking statements, except as required by law.

Contacts

Investors: Fletcher Payne, CFO Catalyst Biosciences, Inc. 1.650.871.0761 investors@catbio.com

Media: Josephine Belluardo, Ph.D. LifeSci Public Relations 1.646.751.4361 jo@lifescipublicrelations.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BAC Shareholders Face Class Action: Fraud Allegations

Updated Category News Views 13

Legal Storm Brewing Over Bank of America If you thought the banking sector was a safe harbor, folks, take a gander at the latest happening with the Bank of America Corporation (NYSE: BAC). The old titans aren't immune to legal turmoil, as evidenced by the ruckus over a $1.2 billion fine slapped on the bank for violations involving anti-money laundering laws. Now, a...

Continue Reading
New Ambulatory Surgery Center in Alabama Breaks Ground

Updated Category News Views 7

Breaking New Ground: USOP and SOS Lead the Charge You can almost hear the construction noise starting up in Montgomery, Alabama, where U.S. Orthopaedic Partners (USOP) and Southern Orthopaedic Surgeons (SOS) have just launched an ambitious new project. They're not just cutting ceremonial ribbons; they're slicing into the future of orthopedic care in Central Alabama. The...

Continue Reading
Medical Device Manufacturing: $135B Market by 2031

Updated Category News Views 89

Skyrocketing Demand in Medical Device Manufacturing You're looking at a market that's gearing up to hit a whopping $135.47 billion by 2031. That's a big leap from its $85.59 billion stature in 2026, showing a strong 9.6% compound annual growth rate (CAGR). Now, if that doesn't get your investor rollercoaster senses tingling, I don't know what will. Key Growth Drivers The...

Continue Reading
National CORE Retains A+ Rating as Housing Demand Soars

Updated Category News Views 47

A Rating That Speaks Volumes in Affordable Housing Fresh out of Rancho Cucamonga, National CORE's announcement of its A+ credit rating reaffirmation is no small potatoes. For the fourth consecutive year, Standard & Poor's Global Ratings has found that this nonprofit affordable housing developer checks all the right boxes for financial strength and strategic prowess. It's...

Continue Reading
Navigating Home Care: What Families Need to Know

Updated Category News Views 70

Peeking into the Home Care Playbook The process of starting home care isn't some mind-boggling puzzle. For families in Northeastern Pennsylvania, things kick off with a cordial chinwag with a care coordinator—no paperwork chains or Kafkaesque contracts right off the bat. Now, if you've got someone in need of care, this gives you time to shove all your questions onto the...

Continue Reading
ALHC Faces Fraud Probe After 16% Stock Plummet

Updated Category News Views 47

Investors Eye Alignment's Tumultuous Turn One thing I don't do is sugarcoat it—stocks get hit hard sometimes, and Alignment Healthcare's recent saga has got jaws dropping across trading floors. It's only October, but Alignment's stock took a chilling nosedive on July 8, to the tune of 16.7%, leaving investors wide-eyed and demanding answers. What caused this seismic...

Continue Reading
transcosmos & Metaverse Creators to Boost VRChat Content

Updated Category News Views 61

Charting the Course for Global VR Expansion transcosmos and Metaverse Creators are throwing down the gauntlet to the barriers between Japanese VR magic and the global market. They're teaming up to sling 3D content from creators in Japan straight to users worldwide via Geek Jack, a cross-border e-commerce bridge built for entertainment. You can't deny it—VRChat's allure...

Continue Reading
USDA Loans in Pampa: Clearing Up Misconceptions

Updated Category News Views 65

Understanding USDA Loans in Pampa When it comes to buying a home in Pampa, Texas, there's a lot of chatter about USDA loans, and a fair bit of confusion too. Now, real estate expert Patti Hudson is cutting through the noise and setting the record straight, making sure families know all the facts before diving into the housing market. Not Just for Rural Areas Let's squash...

Continue Reading
AvePoint Joins S&P SmallCap 600, Replacing LXP

Updated Category News Views 40

Shifting Scenes in the SmallCap Index Wall Street always throws a curveball right when you think you've seen it all. This time, it's AvePoint Inc. (NASD: AVPT) making waves as it steps into the S&P SmallCap 600 ring come November 2. Booting out LXP Industrial Trust (NYSE: LXP), this whole shuffle's coming down because those guys over at Brookfield Asset Management Ltd....

Continue Reading
Lektra Unveils EdgeStart: Green Earnings from AI

Updated Category News Views 54

AI and Solar Power: A New Revenue Stream Lektra's fresh off the blocks with EdgeStart, an AI server pushing building owners to make a buck off their idle solar power. These self-contained, 8-GPU NVIDIA cabinets don't just sit pretty; they’re money-makers, potentially turning an overlooked asset into a goldmine. If your building's solar panels are just loafing about...

Continue Reading

Top 5 Most Recently Viewed Articles

Seeley Holdings Ltd. Engages in Strategic Debt Settlement Deal

Updated Category News Views 163

Overview of Seeley Holdings Ltd.'s Recent Agreement In recent developments, Seeley Holdings Ltd. has taken a significant step by entering into an agreement with Pasinex Resources Limited. As part of this agreement, they will convert a total principal amount of $1,116,636.85 of debt into common shares. This transaction represents a savvy financial maneuver designed to...

Continue Reading
Binance Pre-IPO Perpetuals: OpenAI Enters the Scene

Updated Category News Views 20

Load Up: Binance Expands Pre-IPO Perpetual Offerings A fresh wave of opportunity's hit the crypto shores as Binance broadens its Pre-IPO perpetual offerings with the listing of OPENAIUSDT on their Futures platform. And man, do I smell some serious anticipation cooking! This isn't just a willy-nilly move; the strategy builds on the early firestorm reception to their...

Continue Reading
Carnival Corporation Appoints New Leaders for Cruise Lines

Updated Category News Views 137

Carnival Corporation Announces Leadership Changes Carnival Corporation (LON: CCL), the largest cruise company globally, has recently revealed significant changes in its executive leadership impacting three of its major cruise brands. These brands include Princess Cruises, Holland America Line, and Seabourn, as part of the company's strategy to bolster its market presence....

Continue Reading
Navigating Trade Tensions: Europe's Strategic Responses

Updated Category News Views 104

Understanding US Tariffs and European Reactions The imposition of a 25% import tax on steel and aluminum by the US has spurred trade tensions that extend to Europe. Policymakers in Europe need to consider their responses carefully. As trade barriers rise, the impact on European manufacturers becomes increasingly significant, as exports worth billions are affected. Trade...

Continue Reading
Investors Urged to Join Tronox Holdings Securities Class Action

Updated Category News Views 136

Tronox Holdings Faces Class Action Lawsuit Tronox Holdings plc, known by its ticker symbol TROX, is currently embroiled in a class action lawsuit concerning alleged violations of securities laws. The Schall Law Firm, a firm specializing in shareholder rights litigation, has initiated this action to help affected investors. Understanding the Allegations Investors are...

Continue Reading